Top Premarket Gainers

Pre-market stock movers are worth diving into as we check out all of the hottest news affecting shares on Monday morning!

Moving stocks this morning are clinical trial updates, an acquisition deal and a public offering.

Let’s get into that news below!

Biggest Pre-Market Stock Movers: 10 Top Gainers

• Planet Image stock is rocketing more than 79% alongside heavy pre-market trading.
• Lipella Pharmaceuticals shares are soaring over 58% after initiating a Phase 2a clinical trial.
• Cognition Therapeutics stock is surging more than 44% with positive Phase 2 study results.
• Tivic Health Systems shares are gaining over 32% following a breakdown of its potential catalysts.
• Longeveron stock is increasing more than 22% with the release of Phase 2a study results.
• Pineapple Financial shares are rising 22% without any clear news this morning.
• Cepton stock is climbing over 19% on an acquisition agreement.
• Ambipar Emergency shares are jumping more than 18% this morning.
• BurgerFi stock is heading over 16% higher as it continues a recent rally.
• Vaccinex shares are up more than 15% this morning.

10 Top Losers

• vTv Therapeutics stock is plummeting over 44% after announcing the Food and Drug Administration (FDA) placed a clinical hold on one of its trials.
• CERo Therapeutics shares are diving more than 33% despite a lack of news this morning.
• Treasure Global stock is tumbling over 25% on Monday morning.
• LuxUrban Hotels shares are taking a more than 17% beating after pricing a public offering.
• Invo Bioscience stock is dropping over 11% without any clear news to report.
• Phio Pharmaceuticals  shares are sliding more than 11% this morning.
• Notable Labs stock is decreasing over 10% on Monday morning.
• Regencell Bioscience shares are falling more than 9% after a Friday rally.
• Carbon Revolution stock is slipping over 9% after jumping Friday on a wheels deal.
• Nuwellis shares close out our pre-market stock movers down more than 9%.

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

More from InvestorPlace

• Outstanding GDP Data Suggests it’s ‘Bounce Time’ for Stocks
• Why This Iconic Glass Company Is a Great AI Play
• Is a Global Recession Coming?

Shares of Pitney Bowes Inc. shares rose sharply in today's pre-market trading following a report indicating that the company has sold a part of its e-commerce business to Stord.

Pitney Bowes shares jumped 12.5% to $7.58 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

• Cognition Therapeutics, Inc. gained 46% to $3.45 in pre-market trading after the company announced that it will host an investor presentation to discuss results from its phase 2 SHINE study of CT1812 on Monday July 29, 2024.
• Longeveron Inc. shares climbed 36.3% to $4.69 in pre-market trading after the company disclosed study results from CLEAR MIND Phase 2a clinical trial of Lomecel-B in mild Alzheimer’s disease.
• Planet Image International Limited rose 35.7% to $3.99 in pre-market trading after jumping around 56% on Friday.
• DDC Enterprise Limited shares gained 22.7% to $0.76 in pre-market trading after gaining 6% on Friday.
• BurgerFi International, Inc. gained 22.1% to $0.5133 in pre-market trading. BurgerFi shares jumped 97% on Friday after the company announced it reached a legal settlement agreement with Lion Point Capital. The company agreed to pay $1,350,000 and issue Lion Point 300,000 of preferred stock.
• Tivic Health Systems, Inc. shares gained 19.4% to $0.5395 in pre-market trading after gaining 11% on Friday.
• Ambipar Emergency Response gained 15.5% to $5.34 in pre-market trading after jumping 29% on Friday.
• TransCode Therapeutics, Inc. shares gained 14.1% to $0.3371 in pre-market trading. TransCode Therapeutics 13G filing showed 3i, LP reported a 9.9% stake in the company, as of July 23.
• Anavex Life Sciences Corp. gained 11.4% to $7.51 in pre-market trading. Anavex Life Sciences presented comprehensive results from the Phase IIb/III study showing that blarcamesine, once daily orally, significantly slowed clinical decline in people with early Alzheimer’s disease.

Losers

• vTv Therapeutics Inc. shares fell 37.4% to $13.28 in pre-market trading after the company announced the FDA has placed a clinical hold on the cadisegliatin clinical program which includes the ongoing CATT1 phase 3 trial in type 1 diabetes.
• CERo Therapeutics Holdings, Inc. shares declined 34% to $0.1690 in pre-market trading after gaining 6% on Friday.
• LuxUrban Hotels Inc. shares fell 22.1% to $0.1488 in pre-market trading after the company priced its $1.74 million public offering of 11,573,333 common shares at 15 cents per share.
• Treasure Global Inc. shares fell 19.6% to $1.48 in pre-market trading.
• Globavend Holdings Limited shares declined 13.1% to $0.63 in pre-market trading after surging 24% on Friday.
• Phio Pharmaceuticals Corp. fell 12.6% to $3.53 in pre-market trading. Phio Pharmaceuticals recently announced exercise of warrants for $3.1 million gross proceeds.
• INVO Bioscience, Inc. shares fell 11.6% to $0.7250 in pre-market trading after jumping 11% on Friday.
• NuZee Inc N fell 9.7% to $3.40 in pre-market trading after surging around 25% on Friday.
• EZCORP, Inc. shares dipped 8.8% to $9.41 in pre-market trading.
• Abbott Laboratories shares fell 6.6% to $98.29 in pre-market trading. A jury ordered Abbott to pay $495 million in compensation and damages in a baby-formula verdict, the Wall Street Journal reported.

Now Read This:

• Jim Cramer Is ‘Mystified’ By Five Below, Predicts CrowdStrike ‘Is Going To Bottom Here‘

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

US stock futures were moving modestly lower in Friday's premarket session amid a slew of earnings reports, and ahead of the flash Composite Purchasing Managers' Index, which is set to be released later this morning.

The services PMI rose above the 50 contraction threshold in February for the first time in eight months, and improved to 52.6 in March. The consensus for April is 51.5. Manufacturing, on the other hand, has been below 50 for the last five months, although the index gained nearly 2 points in March to 49.3. The manufacturing consensus for April is 49.2, according to an Econoday survey.

Dow Jones Industrial Average futures were off 0.05%, S&P 500 futures wer down 0.18%, and Nasdaq futures were moving 0.41% lower.

Oil prices were moving higher, with front-month global benchmarks Brent crude and West Texas Intermediate crude rising 0.18% and 0.22% respectively.

Shares of VCI Global Limited surged 23% in Friday's premarket session after it said Thursday that it signed a memorandum of agreement for its proposed acquisition of a 70% stake in digital marketing agency Locus-T. Ambipar Emergency Response shares climbed 8% after a 3.7% loss the previous session. And shares of ContextLogic advanced 22% after it said Thursday that its board approved a share repurchase program of up to $50 million.

Meanwhile, shares of U Power Limited Ordinary Shares tumbled 31%, after soaring 620% Thursday in its Nasdaq debut. Predictive Oncology shares shed 20% after the company said overnight that it will effect a one-for-20 reverse stock split of its shares to maintain its listing eligibility on Nasdaq. And shares of SatixFy Communications fell 17% after surging 61% the previous session.